Skip to main content
WHO Tracker
Main navigation
Home
Items Search
Resolutions Search
Item Alerts Archive
Reports Search
PHM papers
Home
TB
TB
Tuberculosis
TB has reclaimed its place as the world’s biggest infectious killer – but are its days numbered?
May 2024
GLOBAL PLAN TO END TB, 2023-2030 – HOW FEASIBLE? HOW DESIRABLE?
January 2024
Tuberculosis and Inequality: How Race, Caste, and Class Impact Access to Medicines
December 2023
Tuberculosis and Inequality: How Race, Caste, and Class Impact Access to Medicines
December 2023
Johnson & Johnson’s Patenting & Pricing Strategy for TB Medicine Bedaquiline: A Cautionary Tale for New TB Medicines
October 2023
How Advocates Pushed Big Pharma to Cut Tuberculosis Drug Prices
August 2023
Open letter: Requesting clarification from J&J on the recent deal for generic bedaquiline supply
August 2023
TB Preventive Treatment: the Need for Choice
July 2023
Pharma Giant’s TB Drug Decision Welcomed, But Not All Developing Countries Benefit
July 2023
MSF calls for commitment from pharma corporation J&J to not enforce extended patents on lifesaving TB drug as main patent expires in India, opening door to affordable generics
July 2023
Three Indian firms line up to make TB drug Bedaquiline as patent expires
July 2023
Johnson and Johnson shares licence for tuberculosis drug after novelist’s viral campaign
July 2023
Major drug company bends in battle over access to key TB treatment
July 2023
TAG Encouraged by J&J Deal to Reduce Bedaquiline Prices, but Company’s Action Falls Short of Community Demands
July 2023
Global Drug Facility Update on Access to Bedaquiline
July 2023
TB medicine deal offers short-term solution, but J&J needs to do more for all affected countries
July 2023
Gates Foundation to fund trial of long-awaited new tuberculosis vaccine candidate
June 2023
Subscribe to TB